Guggenheim has adjusted its price target for Neogen Corporation (NEOG, Financial), reducing it from $15 to $13. Despite this adjustment, the firm maintains a Buy rating on the company's shares.
The revision comes in light of recent developments involving a change in leadership and an unpredictable macroeconomic environment, which may influence the company's short-term growth prospects. However, analysts suggest that Neogen’s post-integration phase appears to be progressing, indicating potential future stability.
Investors are advised to consider these factors as they might result in some volatility in Neogen's performance in the near term.
